Weihang Peng

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Shengmai Injection as adjunctive therapy in sepsis and septic shock: a retrospective cohort study.

Shengmai Injection as adjunctive therapy in sepsis and septic shock: a retrospective cohort study.

Journal: Frontiers in cellular and infection microbiology

Published: April 30, 2026

Corrigendum to "Uncovering the bidirectional molecular pathway: How shugan wendan decoction treats concurrent depression and atherosclerosis" [J. Ethnopharmacol. (2025) 121096].

Corrigendum to "Uncovering the bidirectional molecular pathway: How shugan wendan decoction treats concurrent depression and atherosclerosis" [J. Ethnopharmacol. (2025) 121096].

Journal: Journal of ethnopharmacology

Published: April 19, 2026

Naoxintong capsule as adjunctive therapy in ACS: a hypothesis-generating open-label randomized trial.

Naoxintong capsule as adjunctive therapy in ACS: a hypothesis-generating open-label randomized trial.

Journal: Frontiers in pharmacology

Published: April 05, 2026

Protective and nephrotoxic effects of emodin in animal models of kidney injury: a systematic review and meta-analysis.

Protective and nephrotoxic effects of emodin in animal models of kidney injury: a systematic review and meta-analysis.

Journal: Frontiers in pharmacology

Published: February 23, 2026

Efficacy and safety of guanxinshutong capsule as adjunctive therapy for unstable angina: an integrated systematic review, meta-analysis, and network pharmacology study.

Efficacy and safety of guanxinshutong capsule as adjunctive therapy for unstable angina: an integrated systematic review, meta-analysis, and network pharmacology study.

Journal: Frontiers in cardiovascular medicine

Published: November 12, 2025

Uncovering the bidirectional molecular pathway: How shugan wendan decoction treats concurrent depression and atherosclerosis.

Uncovering the bidirectional molecular pathway: How shugan wendan decoction treats concurrent depression and atherosclerosis.

Journal: Journal of ethnopharmacology

Published: October 26, 2025

Study on the irradiation control of urease activity and its solidification of red clay to enhance radon reduction.

Study on the irradiation control of urease activity and its solidification of red clay to enhance radon reduction.

Journal: Journal of environmental radioactivity

Published: August 20, 2025

Spatiotemporal organelle delivery and activation of type I AIE photosensitizers and siRNA for near-infrared fluorescence image-guided immunotherapy.

Spatiotemporal organelle delivery and activation of type I AIE photosensitizers and siRNA for near-infrared fluorescence image-guided immunotherapy.

Journal: Biomaterials

Published: July 15, 2025

Modified Dachengqi Decoction ameliorates sepsis-induced lung injury via the gut microbiota-bile acid axis.

Modified Dachengqi Decoction ameliorates sepsis-induced lung injury via the gut microbiota-bile acid axis.

Journal: Frontiers in cellular and infection microbiology

Published: July 08, 2025

Machine learning-based prediction of knee pain risk using lipid metabolism biomarkers: a prospective cohort study from CHARLS.

Machine learning-based prediction of knee pain risk using lipid metabolism biomarkers: a prospective cohort study from CHARLS.

Journal: Frontiers in physiology

Published: April 07, 2025

Efficacy and Potential Mechanism of Chinese Herbal Formula Chaihu Shugan Powder on Animal Models of Depression: A Systematic Review and Meta-Analysis.

Efficacy and Potential Mechanism of Chinese Herbal Formula Chaihu Shugan Powder on Animal Models of Depression: A Systematic Review and Meta-Analysis.

Journal: CNS neuroscience & therapeutics

Published: August 29, 2024

Chaihu Shugan powder restores fatty acid synthesis to alleviate insulin resistance in metabolic syndrome by regulating the LXRα/SREBP-1 signaling pathway.

Chaihu Shugan powder restores fatty acid synthesis to alleviate insulin resistance in metabolic syndrome by regulating the LXRα/SREBP-1 signaling pathway.

Journal: Frontiers in pharmacology

Published: June 14, 2024

Showing 1-12 of 18

Last Updated: 09/26/2026